Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 669-676

  Charrad, Rachida Sihem ^a   Li, Yue ^a   Delpech, Bertrand ^b   Balitrand, Nicole ^c   Clay, Denis ^a   Jasmin, Claude ^a   Chomienne, Christine ^c   Smadja Joffe, Florence ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b CENTRE HENRI BECQUEREL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MONOCLONAL ANTIBODY; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST CELL; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RESPIRATORY BURST;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; ANTIGENS, CD15; ANTIGENS, CD44; BONE MARROW; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; HYALURONIC ACID; LEUKEMIA, MYELOID; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTES; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; RESPIRATORY BURST; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0033067551     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9518     Document Type: Article

References (39)

1. Bennett, J.M., Catovsky, D. & Daniel, M.T. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-British-American Cooperative Group. Ann. Intern. Med. 103, 620-625 (1985).
2. Rowley, J.D., Golomb, H.M. & Dougherty, G.J. 15;17 translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1, 549-550 (1977).
3. Bishop, J.F. et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87, 1710-1717 (1996).
4. Degos, L.C. et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85, 2643-2653 (1995).
5. Legras, S. et al. A strong expression of CD44-6v correlates with shorter survival patients with acute myeloid leukemia. Blood 91, 3401-3413 (1998).
6. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.B. & Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 1303-1313 (1990).
7. Miyake, K., Underhill, C.B., Lesley, J. & Kincade, P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med 172, 69-75 (1990).
8. +. Blood 80, 429-436 (1992).
9. Ghaffari, S., Dougherty, G.J., Lansdorp, P.M., Eaves, A.C. & Eaves, C.J. Differentiation-associated changes in CD44 isoform expressing ruding normal hematopoiesis and their alteration in chronic myeloid leukemia. Blood 86, 2976-2985 (1995).
10. Koopman, G. et al. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol. 145, 3589-3593 (1990).
11. Webb, D.S.A., Shimizu, Y., van Seventer, G.A., Shaw, S. & Gerrard, T.L. LFA-3, CD44 and CD45: physiologic triggers of human monocytes TNF and IL-1 release. Science 249, 1295-1297 (1990).
12. Ayroldi, E. et al. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86, 2672-2678 (1995).
13. Galandrini, R., Galluzzo, E., Albi, N., Grossi, C.E. & Velardi, A. Hyaluronate is costimulatory for human T cell effector functions of human clones. J. Immunol. 153, 21-31 (1994).
14. Delfino, D.V. et al. Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J. Immunol. 152, 5171-5179 (1994).
15. Taher, E. et al. Signaling through CD44 is mediated by tyrosine kinases association with p56lck in T lymphocytes. J. Biol. Chem. 271, 2863-2867 (1996).
16. Trochon, V. et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int. J. Cancer 66, 664-668 (1996).
17. Noble, P.W., Lake, F.R., Henson, P.M. & Riches, D.W.H. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-dependent mechanism in murine macrophages. J. Clin. Invest. 91, 2368-2377 (1993).
18. Noble, P.W., McKee, C.M. & Cowman, M. Hyaluronan fragments activate an NF-kB/I-kB autoregulary loop in murine macrophages. J. Exp. Med. 183, 2373-2378 (1996).
19. Mendelsohn, N., Gilbert, H., Christman, J. & Acs, G. Effects of maturation on the response of human promyelocytic leukemia cells (HL-60) to the tumor promoter 12-O-tetradecanoyl phorbol-13-acetate. Cancer. Res. 40, 1469-1474 (1980).
20. Goyert, S.M. et al. CD14 Workshop Panel Report in Leukocytes Typing VI (eds. Kishimoto, T. et al.) 963-965 (Garland Publishing, New York, 1997).
21. Kannagi R. CD15 Workshop Panel Report in Leukocytes Typing VI (eds. Kishimoto, T. et al.) 348-351 (Garland Publishing, New York, 1997).
22. Griffin, J.D. et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophiles, monocytes, and their precursors. J. Immunol. 145, 576-584 (1990).
23. Huet, S. et al. CD44 contributes to T cell activation: J. Immunol. 142, 798-801 (1989).
24. Denning, S. M., Le P. T., Singer, K.H. & Haynes, B.F. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144, 7-15 (1990).
25. Chomienne, C. et al. All-trans retioic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 76, 1710-1717 (1990).
26. Slack, J.L. & Gallagher, R.E. The molecular biology of acute promyelocytic leukemia. Cancer Treat. Res. 99, 75-124 (1999).
27. Raelson, J.V. et al. The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88, 2826-2832 (1996).
28. Metcalf, D. Hematopoietic regulators. Trends Biol. Sci. 17, 286-290 (1992).
29. Morimoto, K. et al. CD44 mediates hyaluronan binding by human myeloid KG1a and KG1 cells. Blood 83, 657-662 (1994).
30. Zhong, Z. et al. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130, 485-495 (1995).
31. Kincade, P.W., Zhong, Z., Katoh, S. & Hanson, L. The importance of the cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9, 635-642 (1997).
32. Ghaffari, S., Dougherty, G.J., Eaves, A.C. & Eaves, C.J. Altered patterns of CD44 epitope expression in human chronic and acute myeloid leukemia. Leukemia 10, 1773-1781 (1996).
33. Delpech, B., Bertrand, P. & Maingonnat, C. Immunoenzymoassay of the hyaluronic acid-hyaluronectin interaction: application to the detection of hyaluronic acid in serum of normal subjects and cancer patients. Anal. Bioch. 149, 555-565 (1985).
34. Tenen, D.C., Hromas, R., Licht, J.D. & Zhang, D. Transcription factors, normal myeloid development, and leukemia. Blood 90, 489-519 (1997).
35. Terstappen, L.W.M.M. et al. Flow cytometric characterization of acute myeloid leukemia. Part I. Significance of light scattering properties. Leukemia 5, 315-320 (1991).
36. Delpech, B. et al. Interaction of hyaluronectin with hyaluronic acid oligosaccharides. J. Neurochem. 45, 434-439 (1985).
37. Lesley, J., Hyman, R. & Kincade, P.W. CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54, 271-335 (1993).
38. Sambrouk, J., Fritch, E.F. & Maniatis, T. in Molecular Cloning. A Laboratory Manual. (ed. Nolan, C.) 700-787 (Cold Spring Laboratory Press, Cold Spring Harbor, New York, 1989).
39. Conover, W.J. in Practical Nonparametric Statistics 5, 213-338 (J. Wiley and Sons, New York, 1980).